Eli Lilly Executives to be Questioned About Company Lobbying for Unpopular, Unconstitutional ObamaCare Legislation

Shareholder to Ask Company to “Reset” Its Approach and Pledge Support for Free-Market Health Care Reforms in Coming Legislative Battles Indianapolis, IN / Washington, D.C. – The National Center for Public Policy Research plans to question Eli Lilly executives over the company’s lobbying for the … Continue reading Eli Lilly Executives to be Questioned About Company Lobbying for Unpopular, Unconstitutional ObamaCare Legislation